- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Generic Drugs market will register a 10.4% CAGR in terms of revenue, the global market size will reach $ 373670 million by 2025, from $ 251790 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Generic Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by type, application, key manufacturers and key regions and countries.
This study considers the Generic Drugs value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Simple Generic Drugs
Super Generic Drugs
Biosimilars
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Teva
Lupin
Novartis - Sandoz
Sun Pharmaceutical
Aspen
Mylan
Sanofi
Fresenius Kabi
Aurobindo
Pfizer (Hospira)
Krka Group
Valeant
Nichi-Iko Pharmaceutical
Dr. Reddy's
ENDO (Par Pharmaceutical)
Cipla
Hikma
Stada Arzneimittel
Apotex
Zydus Cadila
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Generic Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Generic Drugs market by identifying its various subsegments.
Focuses on the key global Generic Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Generic Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Generic Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Generic Drugs Consumption 2015-2025
2.1.2 Generic Drugs Consumption CAGR by Region
2.2 Generic Drugs Segment by Type
2.2.1 Simple Generic Drugs
2.2.2 Super Generic Drugs
2.2.3 Biosimilars
2.3 Generic Drugs Consumption by Type
2.3.1 Global Generic Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Generic Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Generic Drugs Sale Price by Type (2015-2020)
2.4 Generic Drugs Segment by Application
2.4.1 CNS
2.4.2 Cardiovascular
2.4.3 Genitourinary/Hormonal Drugs
2.4.4 Respiratory
2.4.5 Rheumatology
2.4.6 Diabetes
2.4.7 Oncology
2.4.8 Others
2.5 Generic Drugs Consumption by Application
2.5.1 Global Generic Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Generic Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Generic Drugs Sale Price by Type (2015-2020)
3 Global Generic Drugs by Company
3.1 Global Generic Drugs Sales Market Share by Company
3.1.1 Global Generic Drugs Sales by Company (2018-2020)
3.1.2 Global Generic Drugs Sales Market Share by Company (2018-2020)
3.2 Global Generic Drugs Revenue Market Share by Company
3.2.1 Global Generic Drugs Revenue by Company (2018-2020)
3.2.2 Global Generic Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Generic Drugs Sale Price by Company
3.4 Global Generic Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Generic Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Generic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Generic Drugs by Regions
4.1 Generic Drugs by Regions
4.2 Americas Generic Drugs Consumption Growth
4.3 APAC Generic Drugs Consumption Growth
4.4 Europe Generic Drugs Consumption Growth
4.5 Middle East & Africa Generic Drugs Consumption Growth
5 Americas
5.1 Americas Generic Drugs Consumption by Countries
5.1.1 Americas Generic Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Generic Drugs Value by Countries (2015-2020)
5.2 Americas Generic Drugs Consumption by Type
5.3 Americas Generic Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Generic Drugs Consumption by Regions
6.1.1 APAC Generic Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Generic Drugs Value by Regions (2015-2020)
6.2 APAC Generic Drugs Consumption by Type
6.3 APAC Generic Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Generic Drugs by Countries
7.1.1 Europe Generic Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Generic Drugs Value by Countries (2015-2020)
7.2 Europe Generic Drugs Consumption by Type
7.3 Europe Generic Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Generic Drugs by Countries
8.1.1 Middle East & Africa Generic Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Generic Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Generic Drugs Consumption by Type
8.3 Middle East & Africa Generic Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Generic Drugs Distributors
10.3 Generic Drugs Customer
11 Global Generic Drugs Market Forecast
11.1 Global Generic Drugs Consumption Forecast (2021-2025)
11.2 Global Generic Drugs Forecast by Regions
11.2.1 Global Generic Drugs Forecast by Regions (2021-2025)
11.2.2 Global Generic Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Generic Drugs Forecast by Type
11.8 Global Generic Drugs Forecast by Application
12 Key Players Analysis
12.1 Teva
12.1.1 Company Information
12.1.2 Generic Drugs Product Offered
12.1.3 Teva Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Teva Latest Developments
12.2 Lupin
12.2.1 Company Information
12.2.2 Generic Drugs Product Offered
12.2.3 Lupin Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Lupin Latest Developments
12.3 Novartis - Sandoz
12.3.1 Company Information
12.3.2 Generic Drugs Product Offered
12.3.3 Novartis - Sandoz Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Novartis - Sandoz Latest Developments
12.4 Sun Pharmaceutical
12.4.1 Company Information
12.4.2 Generic Drugs Product Offered
12.4.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sun Pharmaceutical Latest Developments
12.5 Aspen
12.5.1 Company Information
12.5.2 Generic Drugs Product Offered
12.5.3 Aspen Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Aspen Latest Developments
12.6 Mylan
12.6.1 Company Information
12.6.2 Generic Drugs Product Offered
12.6.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mylan Latest Developments
12.7 Sanofi
12.7.1 Company Information
12.7.2 Generic Drugs Product Offered
12.7.3 Sanofi Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Sanofi Latest Developments
12.8 Fresenius Kabi
12.8.1 Company Information
12.8.2 Generic Drugs Product Offered
12.8.3 Fresenius Kabi Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Fresenius Kabi Latest Developments
12.9 Aurobindo
12.9.1 Company Information
12.9.2 Generic Drugs Product Offered
12.9.3 Aurobindo Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Aurobindo Latest Developments
12.10 Pfizer (Hospira)
12.10.1 Company Information
12.10.2 Generic Drugs Product Offered
12.10.3 Pfizer (Hospira) Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Pfizer (Hospira) Latest Developments
12.11 Krka Group
12.11.1 Company Information
12.11.2 Generic Drugs Product Offered
12.11.3 Krka Group Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Krka Group Latest Developments
12.12 Valeant
12.12.1 Company Information
12.12.2 Generic Drugs Product Offered
12.12.3 Valeant Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Valeant Latest Developments
12.13 Nichi-Iko Pharmaceutical
12.13.1 Company Information
12.13.2 Generic Drugs Product Offered
12.13.3 Nichi-Iko Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Nichi-Iko Pharmaceutical Latest Developments
12.14 Dr. Reddy's
12.14.1 Company Information
12.14.2 Generic Drugs Product Offered
12.14.3 Dr. Reddy's Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Dr. Reddy's Latest Developments
12.15 ENDO (Par Pharmaceutical)
12.15.1 Company Information
12.15.2 Generic Drugs Product Offered
12.15.3 ENDO (Par Pharmaceutical) Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 ENDO (Par Pharmaceutical) Latest Developments
12.16 Cipla
12.16.1 Company Information
12.16.2 Generic Drugs Product Offered
12.16.3 Cipla Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Cipla Latest Developments
12.17 Hikma
12.17.1 Company Information
12.17.2 Generic Drugs Product Offered
12.17.3 Hikma Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Hikma Latest Developments
12.18 Stada Arzneimittel
12.18.1 Company Information
12.18.2 Generic Drugs Product Offered
12.18.3 Stada Arzneimittel Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Stada Arzneimittel Latest Developments
12.19 Apotex
12.19.1 Company Information
12.19.2 Generic Drugs Product Offered
12.19.3 Apotex Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Apotex Latest Developments
12.20 Zydus Cadila
12.20.1 Company Information
12.20.2 Generic Drugs Product Offered
12.20.3 Zydus Cadila Generic Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Zydus Cadila Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Generic Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Simpl
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
